UpHealth (UPH) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free UPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media UpHealth Short Interest DataCurrent Short Volume628,900 sharesPrevious Short Volume686,200 sharesChange Vs. Previous Month-8.35%Dollar Volume Sold Short$263,509.10Short Interest Ratio / Days to Cover2.5Last Record DateNovember 30, 2023Outstanding Shares17,775,000 sharesFloat Size8,610,000 sharesShort Percent of Float7.30%Today's Trading Volume348,700 sharesAverage Trading Volume121,201 sharesToday's Volume Vs. Average288% Short Selling UpHealth ? Sign up to receive the latest short interest report for UpHealth and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatUPH Short Interest Over TimeUPH Days to Cover Over TimeUPH Percentage of Float Shorted Over Time Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here UpHealth Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2023628,900 shares $263,509.10 -8.4%7.3%2.5 $0.42 11/15/2023686,200 shares $672,338.76 +1.0%8.0%3.6 $0.98 10/31/2023679,300 shares $665,578.14 -1.4%8.2%29.3 $0.98 10/15/2023689,000 shares $675,082.20 +0.7%8.3%21.9 $0.98 9/30/2023684,100 shares $670,281.18 +2.1%8.2%18.4 $0.98 9/15/2023670,300 shares $804,360.00 +13.9%8.0%16.3 $1.20 Get the Latest News and Ratings for UPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UpHealth and its competitors with MarketBeat's FREE daily newsletter. 8/31/2023588,500 shares $706,200.00 +3.0%7.2%14.6 $1.20 8/15/2023571,200 shares $793,968.00 +7.4%7.0%14.2 $1.39 7/31/2023531,900 shares $840,402.00 +4.7%6.7%14.2 $1.58 7/15/2023507,900 shares $914,220.00 +2.0%6.4%15.7 $1.80 6/30/2023498,200 shares $936,616.00 -5.8%6.3%15.8 $1.88 6/15/2023528,600 shares $861,618.00 -0.8%6.6%17.4 $1.63 5/31/2023533,000 shares $810,160.00 +10.6%6.7%19.9 $1.52 5/15/2023482,000 shares $862,780.00 -1.2%6.3%9.8 $1.79 4/30/2023488,000 shares $844,240.00 +2.3%7.4%10.2 $1.73 4/15/2023477,000 shares $801,360.00 -3.2%7.2%9.7 $1.68 3/31/2023492,900 shares $734,421.00 +4.9%6.4%9.1 $1.49 3/15/2023470,000 shares $803,700.00 +22.6%7.0%7.3 $1.71 2/28/2023383,500 shares $782,340.00 +1.6%5.7%4 $2.04 2/15/2023377,300 shares $928,158.00 +8.7%5.6%4.2 $2.46 1/31/2023347,200 shares $906,192.00 -6.8%5.2%4.9 $2.61 1/15/2023372,400 shares $1.17 million +8.9%5.5%5.3 $3.13 12/30/2022342,000 shares $557,460.00 +2.6%4.9%5.2 $1.63 12/15/2022333,400 shares $696,806.00 +183.7%5.3%6.1 $2.09 11/30/2022117,500 shares $405,962.50 -88.4%1.9%2.7 $3.46 11/15/20221,010,000 shares $427,129.00 +2.1%1.6%5.1 $0.42 10/31/2022989,300 shares $529,077.64 -26.2%1.6%3.5 $0.53 10/15/20221,340,000 shares $669,732.00 -8.2%2.1%4.3 $0.50 9/30/20221,460,000 shares $776,720.00 +37.7%2.6%4.2 $0.53 9/15/20221,060,000 shares $625,400.00 -26.4%1.9%2.9 $0.59 8/31/20221,440,000 shares $879,552.00 +29.7%2.7%3.9 $0.61 8/15/20221,110,000 shares $876,900.00 +8.8%2.1%2.9 $0.79 7/31/20221,020,000 shares $642,600.00 -11.3%1.9%2.7 $0.63 7/15/20221,150,000 shares $572,240.00 -6.5%2.2%2.9 $0.50 6/30/20221,230,000 shares $728,775.00 -14.0%2.4%2.7 $0.59 6/15/20221,430,000 shares $829,972.00 +16.3%2.8%1.9 $0.58 5/31/20221,230,000 shares $915,120.00 -23.1%1.8%1.6 $0.74 5/15/20221,600,000 shares $1.14 million +111.0%2.4%1.9 $0.72 4/30/2022758,300 shares $606,109.19 -9.3%1.1%0.9 $0.80 4/15/2022835,900 shares $822,024.06 +0.4%1.2%1 $0.98The Small Biotech with a BIG Cancer Solution (Ad)There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.Get the full story here >>> UPH Short Interest - Frequently Asked Questions What is UpHealth's current short interest? Short interest is the volume of UpHealth shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 628,900 shares of UPH short. 7.30% of UpHealth's shares are currently sold short. Learn More on UpHealth's current short interest. What is a good short interest ratio for UpHealth? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UPH shares currently have a short interest ratio of 2.0. Learn More on UpHealth's short interest ratio. Which institutional investors are shorting UpHealth? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of UpHealth: Citadel Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for UpHealth? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.30% of UpHealth's floating shares are currently sold short. Is UpHealth's short interest increasing or decreasing? UpHealth saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 628,900 shares, a decline of 8.4% from the previous total of 686,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is UpHealth's float size? UpHealth currently has issued a total of 17,775,000 shares. Some of UpHealth's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. UpHealth currently has a public float of 8,610,000 shares. How does UpHealth's short interest compare to its competitors? 7.30% of UpHealth's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to UpHealth: Exicure, Inc. (2.44%), Fresh Tracks Therapeutics, Inc. (0.17%), Bright Minds Biosciences Inc. (2.67%), Leafly Holdings, Inc. (2.35%), Lixte Biotechnology Holdings, Inc. (1.13%), Minerva Surgical, Inc. (92.12%), Titan Pharmaceuticals, Inc. (2.21%), Shineco, Inc. (0.13%), NanoString Technologies, Inc. (12.55%), Acutus Medical, Inc. (5.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($6.17 billion), Canadian Natural Resources Limited ($3.99 billion), T-Mobile US, Inc. ($3.78 billion), Charter Communications, Inc. ($3.37 billion), Coinbase Global, Inc. ($2.89 billion), Suncor Energy Inc. ($2.83 billion), Occidental Petroleum Co. ($2.64 billion), Tractor Supply ($2.31 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Rivian Automotive, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short UpHealth stock? Short selling UPH is an investing strategy that aims to generate trading profit from UpHealth as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against UpHealth? A short squeeze for UpHealth occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UPH, which in turn drives the price of the stock up even further. How often is UpHealth's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UPH, twice per month. The most recent reporting period available is November, 30 2023. More Short Interest Resources from MarketBeat Related Companies: XCUR Short Squeeze FRTX Short Squeeze DRUG Short Squeeze LFLY Short Squeeze LIXT Short Squeeze UTRS Short Squeeze TTNP Short Squeeze SISI Short Squeeze NSTG Short Squeeze AFIB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:UPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Ackman’s 2024 warningPorter & CompanyWARNING - this content may be disturbingParadigm Press